Welcome to our dedicated page for Enovix Corporation SEC filings (Ticker: ENVXW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Enovix Corporation's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Enovix Corporation's regulatory disclosures and financial reporting.
Form 144 notice for Enovix Corporation (warrants): The filing notifies a proposed brokered sale of 1,914,466 warrants on Nasdaq with an aggregate market value of $2,641,963, scheduled approximately for 08/28/2025. The filing shows total warrants outstanding of 29,233,276, and that the warrants were acquired as dividends from the issuer on 09/24/2020 (519,853 warrants) and 07/13/2021 (1,394,613 warrants). No securities were reported sold by the holder in the past three months. Standard attestation language is included that the seller has no undisclosed material adverse information.
Enovix Corp. director John Daniel McCranie received grants of restricted stock units (RSUs) totaling 40,878 shares on 08/12/2025, recorded on a Form 4 filed 08/26/2025. The filing shows two non‑derivative entries: 25,700 RSUs that will vest in 12 equal quarterly installments beginning August 12, 2025, and 15,178 RSUs with 25% vesting on November 12, 2025, February 12, 2026, May 12, 2026 and the earlier of June 12, 2026 or the company’s 2026 annual meeting (or immediately prior if the director does not stand for or is not re‑elected), subject to continued service.
The transactions are recorded at a $0 price per share, reflecting compensation grants rather than open‑market purchases, and the Form 4 was submitted by an attorney‑in‑fact for the reporting person.
Enovix Corp reporting person Ryan A. Benton, the company’s Chief Financial Officer and a director, received a fully vested award of 5,132 restricted stock units that settled into common stock on 08/22/2025. The filing shows 2,895 shares were withheld to satisfy tax obligations related to that RSU settlement. The report lists the reporting person’s beneficial ownership after the transactions as 753,884 shares in one line and 750,989 shares in another, with explanatory notes indicating the holdings include shares issuable upon settlement of outstanding RSUs.
Enovix Corp (ENVX) Chief Legal Officer Arthi Chakravarthy reported stock activity tied to vested restricted stock units. On 08/22/2025 Ms. Chakravarthy received 5,251 shares upon the settlement of fully vested RSUs that represent her bonus for the quarter ended 06/29/2025. To satisfy tax withholding she permitted the withholding/ disposition of 2,776 shares on 08/22/2025 and an additional 2,217 shares on 08/24/2025, each at a reported price of $10.51. Following these transactions the filing reports beneficial ownership totals of 433,434, then 430,658, and then 428,441 shares, with disclosed shares issuable upon RSU settlement of 343,244, 337,993, and 333,800 respectively. The form is signed 08/26/2025.
Enovix Corp (ENVX) insider Ajay Marathe reported equity transactions on Form 4 dated 08/22/2025. Marathe, who serves as Chief Operating Officer, received 7,449 shares of common stock upon settlement of fully vested restricted stock units (RSUs) that represent a quarterly bonus for the period ended June 29, 2025. To satisfy tax withholding on that issuance, 3,937 shares were withheld and disposed of at a price of $10.51 per share. After these transactions Marathe beneficially owned 1,160,527 shares (the filing also notes 1,164,464 and 1,160,527 as post-transaction tallies reflecting RSU totals). The form was signed by an attorney-in-fact on 08/26/2025.
Enovix Corp (ENVX): Raj Talluri, the company's President, CEO and a director, received a fully vested award of restricted stock units (RSUs) on 08/22/2025 as a quarterly bonus. The grant resulted in the issuance of 14,866 shares of common stock at no cash cost to the reporting person and increased his total reported beneficial ownership to 2,398,067 shares, which includes 1,868,718 shares issuable upon settlement of RSUs.
The filing also shows the withholding of 7,857 shares to satisfy tax obligations related to the RSU settlement; those shares were treated as disposed at an effective price of $10.51, leaving 2,390,210 shares reported after withholding, including 1,853,852 shares issuable upon settlement of RSUs. The Form 4 was signed by an attorney-in-fact on 08/26/2025.